A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults

Clinical trial NCT06326814 · COMPLETED

Trial details

NCT number: NCT06326814
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria

Start date: 2021-10-11
Primary completion: 2023-05-05
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.